UCSF-Led Consortium Receives $26.2M to Develop Therapies for Traumatic Brain Injury
A UCSF-led consortium has received a $26.2 million award from the U.S. Army Medical Materiel Development Activity to develop treatments for traumatic brain injury.
University of California San Francisco
Give to UCSFA UCSF-led consortium has received a $26.2 million award from the U.S. Army Medical Materiel Development Activity to develop treatments for traumatic brain injury.
Researchers have shown that the earliest stages of the brain degeneration associated with Alzheimer’s disease are linked to neuropsychiatric symptoms.
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains.
Ten UCSF postdocs competed to explain complex research in simple language – and in three minutes or less – in the third annual Postdoc Slam held Sept. 26.
Nearly all studies of telomere genetics have been performed in adult populations of European or Asian ancestry, meaning that studies aiming to understand how early environmental exposures impact telomere length across different ethnic groups can’t easily assess the role of natural variations in telomere biology.
In DNA sequencing study of TD, UCSF researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development of this condition.
New research suggests that phototherapy – a treatment for newborns with jaundice – could increase children’s risk of developing epilepsy.
One in seven older veterans with hypertension is discharged with increased blood pressure medications, despite half of those having well-controlled blood pressure prior to their hospital stay.
UCSF researchers have shown that it’s possible to study cellular identity by pulverizing brain tissue samples, extracting their RNA in bulk and looking for signature patterns of gene activity.
Researchers at UCSF and the Gladstone Institutes have received an $18 million grant from the National Institutes of Health to launch the Psychiatric Cell Map Initiative.
As the low-carbohydrate, high-fat ketogenic, or “keto,” diet becomes more popular, scientists at UCSF are among those working to study its potential health benefits and risks.
Most studies of galactic cosmic radiation have used male mice, but new research suggests that female mice may have innate protection against this deep space hazard.
UCSF ranked sixth on the national Best Hospitals Honor Roll and received special recognition for exceptional performance in 15 medical specialties, including top-10 status in a dozen.
Charles Limb, professor of otolaryngology at UCSF, has been fascinated for years by how artists produce unique, emotive, and coherent pieces of music with no sheet music or practice to guide them.
Sun exposure can boost your mood, but it can also significantly boost your risk of skin cancer. Sarah Arron dispels myths around UV rays and gives you her best advice on skin protection.
For the first time, a drug derived from marijuana has been approved by the Food and Drug Administration, and it may soon offer relief to children with hard-to-treat seizures.
Insights into pitch control could pave the way for advanced brain prosthetics that could allow people who can’t speak to express themselves in a naturalistic way.
Sensory Processing Disorder, or SPD, causes some children to find everyday stimuli excruciating. Scientists are finally shedding light on what causes the disorder and what can be done about it.
UCSF scientists have improved mobility in rats that had experienced debilitating strokes by using electrical stimulation to restore a distinctive pattern of brain cell activity associated with efficient movement.
The new research reveals that the brain’s speech centers are organized more according to the physical needs of the vocal tract as it produces speech than by how the speech sounds.
Nationwide study found that more than half of the patients diagnosed with concussion, may fall off the radar shortly after diagnosis, placing in jeopardy treatments for long-term effects.
UCSF neuroscientist identified the first potential treatment for the brain damage caused by exposure to cosmic rays.
Matthew Leonard, who studies the neural basis of word representations, weighs in with a scientific perspective on the debate about “Laurel” versus “Yanny.”
Study led by UCSF scientists shows that brain cells react differently to opioid substances created inside the body than they do to purely synthetic opioid drugs.
Dementia is a possible complication following a concussion, even if the patient did not lose consciousness.
A rear-ender in which the driver’s head slams against the steering wheel or a helmet-to-helmet tussle with an opponent on the football field may increase one’s risk for Parkinson’s disease if concussion results.
The largest analysis to date of genetic data in ALS has identified two previously unrecognized genetic risks that are significantly associated with the disease.
UCSF researchers have shown that an experimental brain boosting drug, ISRIB, acts like a molecular staple, pinning together parts of a much larger protein involved in cellular stress.
UCSF scientists uncovered a common genetic driver of aggressive meningiomas, which could help clinicians detect dangerous cancers earlier and lead to new therapies.
A new study in mice reveals how a gene mutation seen in human short-sleepers may allow them to survive and thrive on just a few hours of sleep.